T2 Biosystems CEO John Sperzel has released a book about his personal experience with a bloodstream infection and sepsis, titled “Courage: Powerful Lessons in Leadership, Strength, and the Will to Succeed.”
Beckman Coulter and Dascena will collaborate to develop and commercialize a novel machine-learning-based algorithm for the detection of sepsis.
A bedside test identifies infants with a genetic mutation of the mitochondrial DNA responsible for irreversible hearing loss as an adverse reaction to the antibiotic gentamicin.
A system uses real-time clinical surveillance and analytics to deliver accurate sepsis alerts and patient-specific treatment advice to clinicians at the point of care.
Read More
The tests for risk assessment and management of sepsis and iron deficiency will be available for sale throughout the European Union.
Read More
Singulex will employ the Thermo Scientific Brahms procalcitonin biomarker to develop a sepsis and systemic inflammatory response syndrome rule-in/rule-out test for use on the Sgx Clarity system.
Read More
The team used publicly available patient gene expression data to pinpoint just seven human genes whose activity changes during an infection.
Read More
New guidelines and advanced tests have enabled earlier diagnosis and improved patient outcomes.
Read More
The procalcitonin antigen can be used to monitor the progression of sepsis and effectiveness of treatment.
Read More
Over the past decade, the number of hospital admissions for sepsis following healthcare-associated infections and community-acquired infections has increased up to three-fold.
Read More
Gram-Negative QuickFISH BC assay is a 20-minute pathogen ID platform for the identification and treatment of sepsis.
Read More
Patrick R. Murray, PhD, formerly a senior scientist at NIH and now with BD, outlines challenges and offers solutions for improving sepsis diagnosis and management.
Read More
Blood Culture Systems Comparison Study Shows BD BACTEC Plus aerobic medium provides statistically significant differences in bacterial recovery for patients on antimicrobial therapy.McKe
Read MoreNew York Gov. Andrew M. Cuomo is pushing hospitals to implement better ways of identifying sepsis.
Read MoreProcalcitonin immunoassay is sustained on VIDAS instruments.
Read MoreCepheid has received a grant from the National Institutes of Health to develop sample processing and amplification methods for highly-sensitive detection of bloodstream bacteria using nested polymerase chain reaction on the GeneXpert System.
Read MoreSeegene announced the availability of Magicplex Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens
Read MoreNew research from The Methodist Hospital in Houston shows that sepsis is 10 times more common and more lethal than other more well-known surgical complications including heart attacks and blood clots.
Read More